NovaBridge Biosciences

NASDAQ:NBP

Biotechnology

Healthcare
$0.90 -4.78%

-$0.07 today

Market cap
$104.10M
Beta
1.48
P/E (TTM)
-25.5
EPS (TTM)
-$0.40
52W Low $1.46High $6.79

Volume 0.87M

Average 0.90M

Balance Sheet

Inspect the capital base behind the business.

Assets

$37.24M

FY 2025 · Annual

-97.6% YoY

Liabilities

$4.23M

FY 2025 · Annual

-95.0% YoY

Equity

$33.02M

FY 2025 · Annual

-97.8% YoY

Balance Sheet

Mixed currencies
Metric
FY2021
Dec 2021 · CNY
FY2022
Dec 2022 · CNY
FY2023
Dec 2023 · CNY
FY2024
Dec 2024 · CNY
FY2025
Dec 2025 · USD
Cash & Equivalents552.8M3.21B291.51M498.24M30.11M
Short-term Investments118.16M235.43M20.22M767.36M30.02K
Net Receivables60.95M4.81M1.83M8.55M256.33K
Inventory4.27M(80.28M)000
Other Current Assets0242.96M15.68M10
Total Current Assets750.18M3.63B329.91M1.29B31.1M
Property, Plant & Equipment (Net)24.87M123.97M5.55M27.72M421.59K
Goodwill25.51M162.57M000
Intangible Assets18.77M118.89M000
Long-term Investments55.24M30.85M0224.98M5.32M
Tax Assets00000
Other Non-current Assets4.18M10.91M33.46M9.96M402K
Total Non-current Assets128.56M447.19M39.01M262.66M6.15M
Total Assets878.74M4.07B368.92M1.55B37.24M
Account Payables00000
Short-term Debt02.75M000
Tax Payables00000
Deferred Revenue371.66K2.19M0773.67K0
Other Current Liabilities0549.85M49.67M5.01M1.31M
Total Current Liabilities97.9M659.74M58.14M61.7M3.84M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)37.49M0106K00
Other Non-current Liabilities15.2M373.53M64.83M3.8K73.05K
Total Non-current Liabilities65.52M405.6M68.19M22.38M384.13K
Total Liabilities163.42M1.07B126.34M84.08M4.23M
Common Stock19.77K132K19K138.68K3.86K
Retained Earnings(683.21M)(6.77B)(1.26B)(9.39B)(190.47M)
Accumulated OCI(29.26M)216.72M39.77M243.66M5.94M
Other Stockholders Equity00000
Minority Interest00000
Total Equity715.33M3.01B242.58M1.47B33.02M
Total Debt17.64M38.29M3.89M28.33M438.46K
Net Debt(535.16M)(3.18B)(287.62M)(469.9M)(29.67M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$30.1M
Short-term Investments$30.0K
Receivables$256.3K
Other Current$698.4K
Total Current Assets$31.1M
PP&E (Net)$421.6K
Long-term Investments$5.3M
Other Non-current$402.0K
Total Non-current Assets$6.1M
Total Assets$37.2M

Analysis

Selected assets total $37.2M for Latest. The largest visible component is Cash & Equivalents at $30.1M, about 80.8% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13D/ASC 13D/A filingNov 5, 2026
3Initial statement of beneficial ownershipNov 2, 2026
6-K6-K filingOct 28, 2026
6-K6-K filingOct 26, 2026
6-K6-K filingOct 23, 2026

How much cash does NBP have?

NovaBridge Biosciences (NBP) reported $30.11M in cash and equivalents in fiscal 2025.

How much debt does NBP carry?

NovaBridge Biosciences (NBP) reported $438,458.00 of total debt, with net debt of -$29.67M.